why choose us

First received: February 06, 2023

Clinical Trial: Glycemic Effect of Diazoxide in NAFLD

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hyperinsulinemia

Study Type: INTERVENTIONAL


Official Title: Role of Hyperinsulinemia in Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis: Diazoxide Pilot & Feasibility Study

Brief Summary: The goal of this clinical trial is to compare a two-week course of diazoxide (at two different doses) and placebo in people with overweight/obesity and insulin resistance (IR) with, or at high risk for, non-alcoholic fatty liver disease (NAFLD).The main questions it aims to answer are how mitigation of compensatory hyperinsulinemia with diazoxide affects parameters of glucose and lipid metabolism (how people with IR and NAFLD respond to lowering high insulin levels so that the investigators can see what…

Read more